SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?


To: Michael Young who wrote (7568)12/20/2002 1:39:13 PM
From: NeuroInvestment  Read Replies (1) | Respond to of 52153
 
Actually, NOT counting Indiplon, they could have three of their own drugs in Phase III by summer: Ocinaplon for GAD, the non-narcotic analgesic bicifadine in acute (post-dental) pain (just started), and their reformulated angina drug--which will go directly into Phase III if the Phase I is OK .

Harry Tracy
NeuroInvestment
www.neuroinvestment.com